Company Encyclopedia
View More
name
Leap Therap
LPTX.US
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd.
1.946 T
LPTX.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Pharmaceutical Stocks To Follow Now - November 17th

    MarketBeat's stock screener tool highlights Eli Lilly, Metsera, Leap Therapeutics, Pfizer, and Jazz Pharmaceuticals as the top pharmaceutical stocks to watch today. These companies have shown significant trading volume recently. Eli Lilly's shares are up 10% following a deal with Trump. Each company is involved in developing and marketing various pharmaceutical products, with potential long-term gains from successful drug commercialization.

    Market Beat·
    US
    LPTX
    0.00%
    US
    LLY
    -1.85%
    Market Beat·
    US
    LPTX
    0.00%
    US
    LLY
    -1.85%

    Key facts: Zcash surges on $59M investment; voting opens for grants

    Zcash (ZECUSD) surged due to institutional interest, notably a $59 million investment from Winklevoss Capital and Leap Therapeutics' rebranding to Cypherpunk Technologies, now managing ZEC assets.1Samson Mow, CEO of JAN3, advised retail traders to prioritize Bitcoin over Zcash (ZEC) for privacy, citing Bitcoin's Lightning Network as sufficient for their needs.2Zcash has opened voting for its Q4 2025 Coinholder-Directed Grants Program, with the poll available until November 25 at 11:59 PM UTC.3

    TradingView·
    US
    GEMI
    +10.22%
    US
    LPTX
    0.00%
    TradingView·
    US
    GEMI
    +10.22%
    US
    LPTX
    0.00%

    Key facts: Zcash Gains Traction; EU Rules Spark Privacy Demand; Winklevoss Launches ZEC Treasury

    Zcash uses zero-knowledge proofs for private transactions, boosting its attractiveness compared to Bitcoin and Ethereum, and has seen significant inflows into the Grayscale Zcash Trust.1Demand for Zcash (ZEC) is rising amid privacy concerns, especially after new EU rules impose strict limits on cash transactions and require identity checks for larger crypto trades.2The Winklevoss twins launched Cypherpunk Technologies, a ZEC-based treasury company, after acquiring and rebranding Leap Therapeutics, highlighting Zcash's potential in the crypto market.3

    TradingView·
    US
    GEMI
    +10.22%
    US
    LPTX
    0.00%
    TradingView·
    US
    GEMI
    +10.22%
    US
    LPTX
    0.00%

    Penny Stocks To Add to Your Watchlist - November 13th

    MarketBeat's stock screener tool highlights seven penny stocks to watch: Leap Therapeutics, Nuvve, Bitfarms, Safe & Green, TNL Mediagene, Strive, and Clearmind Medicine. These stocks are characterized by low prices, high volatility, and speculative nature, making them higher-risk investments. Leap Therapeutics has a Sell rating, while analysts recommend five other stocks as better buys.

    Market Beat·
    US
    TNMG
    +8.51%
    US
    NVVEW
    +4.09%
    US
    NVVE
    -0.65%
    Market Beat·
    US
    TNMG
    +8.51%
    US
    NVVEW
    +4.09%
    US
    NVVE
    -0.65%

    3 Penny Stocks to Watch Now, 11/13/25

    Leap Therapeutics, Amaze Holdings, and Salarius Pharmaceuticals are highlighted as penny stocks to watch on November 13, 2025, according to TipRanks' Penny Stock Screener. These stocks are identified based on high Dollar Volume, a measure of the total value of shares traded. The screener uses filters like Sector, Price Target Upside, and Analyst Consensus to identify promising stocks.

    Tip Ranks·
    US
    SLRX
    +1.28%
    US
    LPTX
    0.00%
    Tip Ranks·
    US
    SLRX
    +1.28%
    US
    LPTX
    0.00%
    © 2025 Longbridge｜Disclaimer